The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A first-in-human study of the potent and highly selective BTK degrader ABBV-101 in patients with relapsed/refractory B-cell malignancies.
 
Elise A. Chong
Consulting or Advisory Role - BeiGene; Novartis; TG Therapeutics
Research Funding - Genentech/Roche
 
Junichiro Yuda
No Relationships to Disclose
 
Koji Izutsu
Honoraria - Abbvie; Abbvie; Allergan; AstraZeneca; Bayer; Bristol Myers Squibb; Bristol-Myers Squibb; Celgene; Chugai Pharma; Daiichi Sankyo; Dainippon Sumitomo Pharma; Eisai; Fujifilm; HUYA Bioscience International; Janssen; Janssen; Kyowa Kirin; Lilly; Meiji Seika Kaisha; Meiji Seika Kaisha; MSD; MSD; Mundipharma; Nippon Kayaku; Novartis; Ono Pharmaceutical; Pfizer; Pfizer; SymBio Pharmaceuticals; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; Bayer; Bristol Myers Squibb; Celgene; Genmab; Kyowa Kirin; Mitsubishi Tanabe Pharma; Nippon Shinyaku; Ono Pharmaceutical
Research Funding - Chugai Pharma; Eisai
 
Luke Benjamin Fletcher
No Relationships to Disclose
 
Wissam Assaily
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Mohammad Sahtout
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Mohamed Badawi
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
John M. Burke
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; AstraZeneca; BeiGene; Bristol Myers Squibb; Foresight Diagnostics; Genentech/Roche; Genmab; Novartis; Nurix; Regeneron; Seagen
Speakers' Bureau - Beigene; Seagen
Travel, Accommodations, Expenses - Genentech/Roche
 
James P. Dean
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Claudina Stevenson
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Christine Will
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
William G. Wierda
Consulting or Advisory Role - Sanofi
Research Funding - Abbvie; Acerta Pharma; Bristol-Myers Squibb; Cyclacel; Genentech; Gilead Sciences; GlaxoSmithKline/Novartis; Janssen; Juno Therapeutics; Kite, a Gilead company; Loxo; MDACC Cancer Center Support Grant; NIH/NCI award number CA016672; Novartis; Numab; Nurix; Oncternal Therapeutics, Inc; Pharmacyclics; Xencor